Unknown

Dataset Information

0

Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC).


ABSTRACT: BACKGROUND AND AIMS:Familial hypercholesterolaemia (FH) is an autosomal-dominant disease with frequency of 1/500 to 1/250 that leads to premature coronary heart disease. New approaches to identify FH mutation-carriers early are needed to prevent premature cardiac deaths. In a cross-sectional study of the Avon Longitudinal Study of Parents and Children (ALSPAC), we evaluated the biochemical thresholds for FH screening in childhood, and modelled a two-stage biochemical and sequencing screening strategy for FH detection. METHODS:From 5083 ALSPAC children with cholesterol measurement at age nine years, FH genetic diagnosis was performed in 1512 individuals, using whole-genome or targeted sequencing of known FH-causing genes. Detection rate (DR) and false-positive rate (FPR) for proposed screening thresholds (total-cholesterol > 1.53, or LDL-C > 1.84 multiples of the median (MoM)) were assessed. RESULTS:Six of 1512 sequenced individuals had an FH-causing mutation of whom five had LDL-C > 1.84 MoM, giving a verification-bias corrected DR of 62.5% (95% CI: 25-92), with a FPR of 0.2% (95% CI: 0.1-0.4). The DR for the TC cut-point of 1.53 MoM was 25% (95% CI: 3.2-65.1) with a FPR of 0.4% (95% CI: 0.2-0.6). We estimated 13 of an expected 20 FH mutation carriers (and 13 of the 20 parental carriers) could be detected for every 10,000 children screened, with false-positives reliably excluded by addition of a next generation sequencing step in biochemical screen-positive samples. CONCLUSIONS:Proposed cholesterol thresholds for childhood FH screening were less accurate than previously estimated. A sequential strategy of biochemical screening followed by targeted sequencing of FH genes in screen-positive children may help mitigate the higher than previously estimated FPR and reduce wasted screening of unaffected parents.

SUBMITTER: Futema M 

PROVIDER: S-EPMC5414415 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC).

Futema Marta M   Cooper Jackie A JA   Charakida Marietta M   Boustred Christopher C   Sattar Naveed N   Deanfield John J   Lawlor Debbie A DA   Timpson Nicholas J NJ   Humphries Steve E SE   Hingorani Aroon D AD  

Atherosclerosis 20170308


<h4>Background and aims</h4>Familial hypercholesterolaemia (FH) is an autosomal-dominant disease with frequency of 1/500 to 1/250 that leads to premature coronary heart disease. New approaches to identify FH mutation-carriers early are needed to prevent premature cardiac deaths. In a cross-sectional study of the Avon Longitudinal Study of Parents and Children (ALSPAC), we evaluated the biochemical thresholds for FH screening in childhood, and modelled a two-stage biochemical and sequencing scree  ...[more]

Similar Datasets

| S-EPMC7199499 | biostudies-literature
| S-EPMC6281007 | biostudies-literature
| S-EPMC3600619 | biostudies-literature
| S-EPMC6764237 | biostudies-literature
| S-EPMC6589926 | biostudies-literature
| S-EPMC7718240 | biostudies-literature
| S-EPMC6115984 | biostudies-other
| S-EPMC6971848 | biostudies-literature
| S-EPMC6389726 | biostudies-literature
| S-EPMC5553108 | biostudies-literature